Clinical Trials Browser

Has results × Medulloblastoma × Topotecan × Clear all

NCT00601003 2024-08-06

Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma

Phase 2 Completed

112 enrolled 10 charts

Medulloblastoma, Neuroblastoma